Assessment and Benchmarking of Model Informed Approaches in Drug Development for Hemoglobinopathies: A Review of Scientific Advices From January 2000 to December 2024. [PDF]
CPT Pharmacometrics Syst PharmacolGovere GS, Dogné JM, Musuamba F.
europepmc +1 more source
Diagnostic Limitations of Hemoglobin A1c in the Setting of Compound Hemoglobinopathy: A Case Report of Sickle Cell Disease, Alpha Thalassemia, and Occult Diabetes. [PDF]
CureusToperzer K, Moon A.
europepmc +1 more source
High-performance liquid chromatography screening reveals HbS/β+-thalassemia double heterozygosity as a pediatric muscular dystrophy mimic. [PDF]
Lab MedLópez-Medina C +5 more
europepmc +1 more source
Newborn Screening for Hemoglobinopathies and Thalassemias: Brief History, Recent Activities, and Global Status-2026. [PDF]
Int J Neonatal ScreenTherrell BL.
europepmc +1 more source
Birth Prevalence of Sickle Cell Disease in India: A Systematic Review and Meta-Analysis. [PDF]
Int J Neonatal ScreenRahiman EA, Anne RP, Warrier RP.
europepmc +1 more source
miRNA-Mediated Regulation of γ-Globin to β-Globin Switching: Therapeutic Potential in β-Hemoglobinopathies. [PDF]
Int J Mol SciAlotaibi D +11 more
europepmc +1 more source
The Heterogeneous Global Burden of Hemoglobinopathies Among Women of Childbearing Age, 1990-2021, with Projection to 2030. [PDF]
Int J Womens HealthWu H +5 more
europepmc +1 more source
Coinheritance of non‐deletional hemoglobin H disease with sickle cell trait
eJHaemVeroniki Komninaka +1 more
doaj +1 more source
Heterozygous ABCC6 mutation in a patient with sickle cell disease: Pseudoxanthoma elasticum or pseudoxanthoma elasticum-like phenotype? [PDF]
JAAD Case RepCamuñas JC +4 more
europepmc +1 more source